Puma Biotechnology's (PBYI) Lowest Price: $1.6400 (on 05-11-2022)
Puma Biotechnology Surging
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotechnology
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma Biotechnology, Inc. | CDISC
Dennis Sanders - Senior Clinical Specialist - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2023 (History)
Puma Biotechnology Inc. | BioWorld
Should You Buy Puma Biotechnology Inc (PBYI) Stock After it Has Gained 6.09% in a Week?
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Puma Biotechnology
Chris Culotta - Associate Director, Accounting - Puma Biotechnology, Inc. | LinkedIn
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology, Inc.
Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
